Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.

Novartis researchers aim to preserve kidney function – and quality of life – for patients.

Novartis researchers are using data to accelerate drug development.

These stories offer a glimpse into the lives of people touched by a new era of medicine.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Explaining Chagas disease through the stories of patients in Latin America.

Lisa, a patient living with CML, shares her experience and discusses the importance of speaking up about unmet needs in your disease.

Alice Shaw, Global Head of Translational Clinical Oncology at Novartis, applies lessons from running clinical trials to the work of designing them.

Novartis is taming nuclear power and putting it to use to treat advanced cancer.

Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.